3-(2-Benzyloxy-phenoxy)-propandiol-(1,2) | 93006-78-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-(2-Benzyloxy-phenoxy)-propandiol-(1,2)
• 英文别名: 3-(2-benzyloxy-phenoxy)-propane-1,2-diol；3-(2-Benzyloxy-phenoxy)-propan-1,2-diol；3-[2-(phenylmethoxy)phenoxy]-1,2-propanediol；3-(2-benzyloxy)phenoxy-1,2-propanediol；3-(o-Benzyloxyphenoxy)-1,2-propanediol；3-(2-phenylmethoxyphenoxy)propane-1,2-diol
• CAS: 93006-78-1
• 化学式: C₁₆H₁₈O₄
• 分子量: 274.317
• InChiKey: DWFXXPGZPLELIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  58.9
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2-Benzyloxy-phenoxy)-propandiol-(1,2) 在 palladium on activated charcoal 吡啶 、 氢气 作用下， 以 异丙醇 、 苯 为溶剂， 生成 3-(2-Hydroxy-phenoxy)-1,2-bis-methylcarbamoyloxy-propan
  参考文献：
  名称：

  CATECHOL单甘油醚氨基甲酸酯。

  摘要：

  DOI：

  10.1002/jps.2600521009
• 作为产物：
  描述：

  2-苯甲氧基苯酚 、 3-氯-1,2-丙二醇 在 ammonium chloride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 3-(2-Benzyloxy-phenoxy)-propandiol-(1,2)
  参考文献：
  名称：

  Process for preparation of 1,4-benzodioxane derivative

  摘要：

  一种用于制备1,4-苯二氧杂环丙烷衍生物的新工艺，其化学式如下（1），该衍生物是循环药物和精神神经病药物的有用中间体，其特点在于用磺酰卤化物对苯氧基丙二醇进行磺化，去除保护基，然后通过碱处理使磺化化合物环化，如有必要，进一步进行磺化。在上述化学式中，R.sup.1为H，RSO.sub.2，R为烷基，苯基，可能被烷基取代，R.sup.2，R.sup.3，R.sup.4为H，卤素，羟基，硝基，氰基，甲酰基，羧基，烷氧羰氧基，烷基，烷氧基，卤代烷基，N，N-二烷基氨基，烷基羰基，烷氧羰基，苯基，可能被烷基取代等。

  公开号：

  US05780650A1

文献信息

• Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants
  申请人：A. H. Robins Co., Inc.

  公开号：US05025031A1

  公开（公告）日：1991-06-18

  Herein disclosed is a method of treating convulsions with a pharmaceutical composition containing a compound of the formula: (HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.z where A is an aryl, arylalkyl, or aryloxyalkyl group and is substituted on 1 or more carbon atoms with a sulfamate group (--OSO.sub.2 NR.sup.1 R.sup.2) wherein R.sup.1 and R.sup.2, same or different, are hydrogen or loweralkyl wherein p is 0 or 1 and is the number of untreated hydroxyl groups and z is 1 or 2 and is the number of --OS(O.sub.2)NR.sup.1 R.sup.2 groups. Aryl is selected from phenyl, substituted phenyl, pyridinyl, naphthyl, quinolinyl, and the like. Phenyl substituents are selected from hydrogen, halo, hydroxy, phenyl, phenoxy, benzoyl, loweralkyl, loweralkoxy, carboxy, amino, loweralkylamino, diloweralkylamino, acetamido, cyano, nitro, loweralkoxycarboyl, aminosulfonyl, imidazolyl, triazolyl, and the like. Novel compounds not previously disclosed are also described.

  以下披露了一种使用含有化合物的药物组合物来治疗惊厥的方法：(HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.z，其中A是芳基、芳基烷基或芳氧烷基基团，并在1个或多个碳原子上用磺酰胺基团(--OSO.sub.2 NR.sup.1 R.sup.2)取代，其中R.sup.1和R.sup.2，相同或不同，是氢或较低烷基，其中p为0或1，是未处理的羟基团的数量，z为1或2，是--OS(O.sub.2)NR.sup.1 R.sup.2基团的数量。芳基选自苯基、取代苯基、吡啶基、萘基、喹啉基等。苯基取代基选自氢、卤素、羟基、苯基、苯氧基、苯甲酰基、较低烷基、较低烷氧基、羧基、氨基、较低烷基氨基、二较低烷基氨基、乙酰胺基、氰基、硝基、较低烷氧羰基、氨基磺酰基、咪唑基、三唑基等。还描述了以前未披露的新化合物。
• Compounds having one or more aminosulfaonyloxy radicals useful as
  申请人：A. H. Robins Company, Incorporated

  公开号：US05194446A1

  公开（公告）日：1993-03-16

  Methods of treating chronic arthritis and osteoporosis which utilize both known and novel compounds which would fall under the general formula: (HO)p--A--[--OS(O).sub.2 NR.sup.1 R.sup.2 ].sub.z wherein A encompasses a wide range of values including but not limited to aryl, loweralkyl, cycloalkyl, and carbohydrates including sucrose and fructose; p is equal to the number of unreacted hydroxy groups contained on the molecule and may be zero; z is the number of --OS(O).sub.2 NR.sup.1 R.sup.2 groups and is always at least one; R.sup.1 and R.sup.2 are selected from hydrogen, loweralkyl, carboxy and the like; a novel process for preparing the compounds is provided wherein an appropriate sulfamic acid aryl ester is reacted with a hydroxy substituted A radical which may or may not contain thereon protected carboxyl, amino or hydroxy substituents, in an aprotic solvent containing a tertiary amine base. Pharmaceutical compositions for the treatment of chronic arthritis and osteoporosis are also provided.

  治疗慢性关节炎和骨质疏松症的方法利用已知和新颖的化合物，这些化合物可归入一般公式：(HO)p--A--[--OS(O).sub.2 NR.sup.1 R.sup.2 ].sub.z，其中A包括一系列值，包括但不限于芳基、较低烷基、环烷基和碳水化合物，包括蔗糖和果糖；p等于分子中未反应的羟基数，可以为零；z是--OS(O).sub.2 NR.sup.1 R.sup.2基团的数量，始终至少为一；R.sup.1和R.sup.2从氢、较低烷基、羧基等中选择；提供了一种制备这些化合物的新方法，其中适当的磺酸酯与含有保护羧基、氨基或羟基取代基的羟基取代的A基团在含有三级胺碱的无水溶剂中反应。还提供了用于治疗慢性关节炎和骨质疏松症的药物组合物。
• Compounds having one or more aminosulfonyloxy radicals useful as
  申请人：A. H. Robins Company, Incorporated

  公开号：US05273993A1

  公开（公告）日：1993-12-28

  Methods of treating chronic arthritis and osteoporosis which utilize both known and novel compounds which would fall under the general formula: (HO)p--A--[--OS(O).sub.2 NR.sup.1 R.sup.2 ].sub.z wherein A encompasses a wide range of values including but not limited to aryl, loweralkyl, cycloalkyl, and carbohydrates including sucrose and fructose; p is equal to the number of unreacted hydroxy groups contained on the molecule and may be zero; z is the number of --OS(O).sub.2 NR.sup.1 R.sup.2 groups and is always at least one; R.sup.1 and R.sup.2 are selected from hydrogen, loweralkyl, carboxy and the like; a novel process for preparing the compounds is provided wherein an appropriate sulfamic acid aryl ester is reacted with a hydroxy substituted A radical which may or may not contain thereon protected carboxyl, amino or hydroxy substituents, in an aprotic solvent containing a tertiary amine base. Pharmaceutical compositions for the treatment of chronic arthritis and osteoporosis are also provided.

  本发明涉及治疗慢性关节炎和骨质疏松症的方法，利用已知和新颖化合物，这些化合物可归为以下一般式：（HO）p-A-[-OS（O）.sub.2 NR.sup.1 R.sup.2].sub.z，其中A包括一系列值，包括但不限于芳基，低烷基，环烷基和碳水化合物，包括蔗糖和果糖；p等于分子中未反应的羟基数，可以为零；z是-OS（O）.sub.2 NR.sup.1 R.sup.2基团的数量，始终至少为一；R.sup.1和R.sup.2从氢，低烷基，羧基等中选择；提供了一种新颖的制备该化合物的过程，其中适当的磺酸芳基酯与含有保护羧基，氨基或羟基取代基团的羟基取代A基团在无极溶剂中反应，其中含有三级胺碱。还提供了用于治疗慢性关节炎和骨质疏松症的药物组合物。
• Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
  申请人：A.H. ROBINS COMPANY, INCORPORATED

  公开号：EP0403185A2

  公开（公告）日：1990-12-19

  The invention concerns known and novel compounds which fall under the general formula: wherein A encompasses a wide range of values including but not limited to aryl, loweralkyl, cycloalkyl, and carbohydrates including sucrose and fructose; p is equal to the number of hydroxy groups on A and may be zero; z is the number of -OS(O)2NR1R2 groups and is always at least one; R1 and R2 are selected from hydrogen, loweralkyl, carboxy and the like; which compounds are useful for treating chronic arthritis and osteoporosis. A novel process for preparing the compounds is provided wherein an appropriate sulfamic acid aryl ester is reacted with a a hydroxy substituted A radical which may or may not contain thereon protected carboxyl, amino or hydroxy substituents, in an aprotic solvent containing a tertiary amine base. Pharmaceutical compositions for the treatment of chronic arthritis and osteoporosis are also provided.

  本发明涉及属于通式的已知和新型化合物： 其中，A 的数值范围很广，包括但不限于芳基、低级烷基、环烷基以及包括蔗糖和果糖在内的碳水化合物；p 等于 A 上羟基的数目，可以是零；z 是 -OS(O)2NR1R2 基团的数目，总是至少一个；R1 和 R2 选自氢、低级烷基、羧基等；这些化合物可用于治疗慢性关节炎和骨质疏松症。本发明提供了一种制备这些化合物的新工艺，即在含有叔胺基的钝溶剂中，将适当的氨基磺酸芳基酯与羟基取代的 A 基反应，A 基上可以含有或不含有受保护的羧基、氨基或羟基取代基。此外，还提供了用于治疗慢性关节炎和骨质疏松症的药物组合物。
• PROCESS FOR PRODUCING 1,4-BENZODIOXANE DERIVATIVES
  申请人：DAISO CO., LTD.

  公开号：EP0841334A1

  公开（公告）日：1998-05-13

  A novel process for preparing a 1,4 benzodioxane derivative shown by the formula (1) which is a useful intermediate of circulatory drugs and drugs for psychoneurosis, characterized in sulfonating a phenoxypropanediol with a sulfonyl halide, eliminating the protective group, and then cyclizing the sulfonated compound by treating with a base followed by, if necessary, further sulfonation. In the above formula, R1 is H, RSO2, R is alkyl, phenyl which may be substituted with alkyl, R2, R3, R4 are H, halogen, OH, nitro, cyano, formyl, COOH, alkoxycarbonyloxy, alkyl, alkoxy, haloalkyl, N,N-dialkylamino, alkylcarbonyl, alkoxycarbonyl, phenyl which may be substituted by alkyl, etc.22

  一种制备式（1）所示的 1,4-苯并二噁烷衍生物的新工艺，该衍生物是循环系统药物和精神神经药物的有用中间体，其特征在于用磺酰卤磺化苯氧基丙二醇，消除保护基，然后用碱环化磺化化合物，必要时再进行进一步磺化。 在上式中，R1 是 H、RSO2，R 是烷基、可被烷基取代的苯基，R2、R3、R4 是 H、卤素、OH、硝基、氰基、甲酰基、COOH、烷氧基羰氧基、烷基、烷氧基、卤代烷基、N,N-二烷基氨基、烷基羰基、烷氧基羰基、可被烷基取代的苯基等22。